Pricing
Login
Home
Charts
Search
Watchlist
Products

Rubicon Research Ltd

RUBICON
₹1,718.70-0.21%20 Nov 2026
Reports
Pharma Formulations

Rubicon Research Ltd

RUBICON
₹1,718.70
-0.21%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹28,451Cr
Close
Close Price
₹1,718.70
Industry
Industry
Pharma Formulations
PE
Price To Earnings
87.07
PS
Price To Sales
13.55
Revenue
Revenue
₹2,100Cr
Rev Gr TTM
Revenue Growth TTM
46.25%
PAT Gr TTM
PAT Growth TTM
89.42%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
296313358352412476514534576
Growth YoY
Revenue Growth YoY%
39.251.743.551.639.9
Expenses
ExpensesCr
234244286273318367395405432
Operating Profit
Operating ProfitCr
6270727994108119129144
OPM
OPM%
20.822.320.222.422.922.723.124.225.0
Other Income
Other IncomeCr
300114362
Interest Expense
Interest ExpenseCr
781211111010911
Depreciation
DepreciationCr
8910101212121518
PBT
PBTCr
49535160729199110117
Tax
TaxCr
151515161818222627
PAT
PATCr
343836435473778590
Growth YoY
PAT Growth YoY%
56.291.2111.895.867.9
NPM
NPM%
11.712.210.112.313.115.314.915.915.7
EPS
EPS₹
2.32.52.42.83.54.54.75.15.5
QuarterSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
296313358352412476514534576
Growth YoY
Revenue Growth YoY%
39.251.743.551.639.9
Expenses
ExpensesCr
234244286273318367395405432
Operating Profit
Operating ProfitCr
6270727994108119129144
OPM
OPM%
20.822.320.222.422.922.723.124.225.0
Other Income
Other IncomeCr
300114362
Interest Expense
Interest ExpenseCr
781211111010911
Depreciation
DepreciationCr
8910101212121518
PBT
PBTCr
49535160729199110117
Tax
TaxCr
151515161818222627
PAT
PATCr
343836435473778590
Growth YoY
PAT Growth YoY%
56.291.2111.895.867.9
NPM
NPM%
11.712.210.112.313.115.314.915.915.7
EPS
EPS₹
2.32.52.42.83.54.54.75.15.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2633153143948541,2841,7542,100
Growth
Revenue Growth%
19.6-0.425.5117.050.436.646.3
Expenses
ExpensesCr
1822233533756991,0201,3541,600
Operating Profit
Operating ProfitCr
8192-3918155264400500
OPM
OPM%
30.629.1-12.54.718.120.622.823.8
Other Income
Other IncomeCr
18101725194814
Interest Expense
Interest ExpenseCr
69101931374241
Depreciation
DepreciationCr
1829343639374557
PBT
PBTCr
7463-66-11103195321417
Tax
TaxCr
25321612607492
PAT
PATCr
4931-67-1791134247325
Growth
PAT Growth%
-37.9-318.774.8638.947.683.689.4
NPM
NPM%
18.89.8-21.4-4.310.710.514.115.5
EPS
EPS₹
97.560.5-4.4-1.16.08.815.519.7
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2633153143948541,2841,7542,100
Growth
Revenue Growth%
19.6-0.425.5117.050.436.646.3
Expenses
ExpensesCr
1822233533756991,0201,3541,600
Operating Profit
Operating ProfitCr
8192-3918155264400500
OPM
OPM%
30.629.1-12.54.718.120.622.823.8
Other Income
Other IncomeCr
18101725194814
Interest Expense
Interest ExpenseCr
69101931374241
Depreciation
DepreciationCr
1829343639374557
PBT
PBTCr
7463-66-11103195321417
Tax
TaxCr
25321612607492
PAT
PATCr
4931-67-1791134247325
Growth
PAT Growth%
-37.9-318.774.8638.947.683.689.4
NPM
NPM%
18.89.8-21.4-4.310.710.514.115.5
EPS
EPS₹
97.560.5-4.4-1.16.08.815.519.7
Sales CAGR
1 Year37%
3 Years65%
5 Years41%
TTM46%
EBITDA CAGR
1 Year51%
3 Years179%
5 Years34%
TTM58%
PAT CAGR
1 Year84%
3 Years-
5 Years52%
TTM89%
Avg. ROCE
1 Year23%
3 Years21%
5 Years11%
TTM25%
CFO / EBITDA
1 Year51%
3 Years47%
5 Years31%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
555515151717
Reserves
ReservesCr
3353693002813705261,2721,400
Current Liabilities
Current LiabilitiesCr
78111184361573786836953
Non Current Liabilities
Non Current LiabilitiesCr
125371102152124202377
Total Liabilities
Total LiabilitiesCr
4305385607501,1091,4512,3272,761
Current Assets
Current AssetsCr
2653403285027631,0631,6821,747
Non Current Assets
Non Current AssetsCr
1661982312483463886451,014
Total Assets
Total AssetsCr
4305385607501,1091,4512,3272,761
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
555515151717
Reserves
ReservesCr
3353693002813705261,2721,400
Current Liabilities
Current LiabilitiesCr
78111184361573786836953
Non Current Liabilities
Non Current LiabilitiesCr
125371102152124202377
Total Liabilities
Total LiabilitiesCr
4305385607501,1091,4512,3272,761
Current Assets
Current AssetsCr
2653403285027631,0631,6821,747
Non Current Assets
Non Current AssetsCr
1661982312483463886451,014
Total Assets
Total AssetsCr
4305385607501,1091,4512,3272,761

Cash Flow

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
562-63-7521159205
Investing Cash Flow
Investing Cash FlowCr
-84-46-55-34-69-65-410
Financing Cash Flow
Financing Cash FlowCr
80526312344-40283
Net Cash Flow
Net Cash FlowCr
167-5514-45578
Free Cash Flow
Free Cash FlowCr
662-63-752191-24
CFO To PAT
CFO To PAT%
11.1200.993.3442.623.1118.583.1
CFO To EBITDA
CFO To EBITDA%
6.867.3159.7-404.213.660.251.2
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
562-63-7521159205
Investing Cash Flow
Investing Cash FlowCr
-84-46-55-34-69-65-410
Financing Cash Flow
Financing Cash FlowCr
80526312344-40283
Net Cash Flow
Net Cash FlowCr
167-5514-45578
Free Cash Flow
Free Cash FlowCr
662-63-752191-24
CFO To PAT
CFO To PAT%
11.1200.993.3442.623.1118.583.1
CFO To EBITDA
CFO To EBITDA%
6.867.3159.7-404.213.660.251.2

Ratios

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
12,72728,451
Price To Earnings
Price To Earnings
51.787.1
Price To Sales
Price To Sales
7.313.6
Price To Book
Price To Book
9.920.1
EV To EBITDA
EV To EBITDA
31.757.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
76.976.156.457.860.364.062.962.9
OPM
OPM%
30.629.1-12.54.718.120.622.823.8
NPM
NPM%
18.89.8-21.4-4.310.710.514.115.5
ROCE
ROCE%
22.015.9-11.71.316.624.122.725.2
ROE
ROE%
14.58.2-22.0-5.923.624.819.122.9
ROA
ROA%
11.55.7-12.0-2.38.29.310.611.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
12,72728,451
Price To Earnings
Price To Earnings
51.787.1
Price To Sales
Price To Sales
7.313.6
Price To Book
Price To Book
9.920.1
EV To EBITDA
EV To EBITDA
31.757.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
76.976.156.457.860.364.062.962.9
OPM
OPM%
30.629.1-12.54.718.120.622.823.8
NPM
NPM%
18.89.8-21.4-4.310.710.514.115.5
ROCE
ROCE%
22.015.9-11.71.316.624.122.725.2
ROE
ROE%
14.58.2-22.0-5.923.624.819.122.9
ROA
ROA%
11.55.7-12.0-2.38.29.310.611.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr41,45838,67735,49928,45122,44020,46118,275
Close PriceClose₹3,317.702,408.902,184.401,718.70822.651,040.951,317.20
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE32.8253.2286.5587.0728.4724.2525.60
Price To SalesPS6.679.329.4613.553.812.415.49
RevenueRevenueCr6,2174,1483,7512,1005,8958,4773,330
Revenue Growth TTMRev Gr TTM%25.0%5.9%25.7%46.3%21.8%19.7%11.1%
PAT Growth TTMPAT Gr TTM%29.7%7.6%894.1%89.4%39.1%32.9%60.0%
Market CapitalizationMkt CapCr41,45838,67735,49928,45122,44020,46118,275
Close PriceClose₹3,317.702,408.902,184.401,718.70822.651,040.951,317.20
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE32.8253.2286.5587.0728.4724.2525.60
Price To SalesPS6.679.329.4613.553.812.415.49
RevenueRevenueCr6,2174,1483,7512,1005,8958,4773,330
Revenue Growth TTMRev Gr TTM%25.0%5.9%25.7%46.3%21.8%19.7%11.1%
PAT Growth TTMPAT Gr TTM%29.7%7.6%894.1%89.4%39.1%32.9%60.0%